265 related articles for article (PubMed ID: 18632849)
1. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.
Troeberg L; Fushimi K; Khokha R; Emonard H; Ghosh P; Nagase H
FASEB J; 2008 Oct; 22(10):3515-24. PubMed ID: 18632849
[TBL] [Abstract][Full Text] [Related]
2. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
3. Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes.
Takizawa M; Yatabe T; Okada A; Chijiiwa M; Mochizuki S; Ghosh P; Okada Y
FEBS Lett; 2008 Aug; 582(19):2945-9. PubMed ID: 18671975
[TBL] [Abstract][Full Text] [Related]
4. Drug insight: aggrecanases as therapeutic targets for osteoarthritis.
Fosang AJ; Little CB
Nat Clin Pract Rheumatol; 2008 Aug; 4(8):420-7. PubMed ID: 18577998
[TBL] [Abstract][Full Text] [Related]
5. Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
Lim NH; Kashiwagi M; Visse R; Jones J; Enghild JJ; Brew K; Nagase H
Biochem J; 2010 Oct; 431(1):113-22. PubMed ID: 20645923
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.
Verma P; Dalal K
J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191
[TBL] [Abstract][Full Text] [Related]
7. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.
Wayne GJ; Deng SJ; Amour A; Borman S; Matico R; Carter HL; Murphy G
J Biol Chem; 2007 Jul; 282(29):20991-8. PubMed ID: 17470431
[TBL] [Abstract][Full Text] [Related]
8. Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures.
Munteanu SE; Ilic MZ; Handley CJ
Arthritis Rheum; 2000 Oct; 43(10):2211-8. PubMed ID: 11037880
[TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.
Yamamoto K; Owen K; Parker AE; Scilabra SD; Dudhia J; Strickland DK; Troeberg L; Nagase H
J Biol Chem; 2014 Mar; 289(10):6462-6474. PubMed ID: 24474687
[TBL] [Abstract][Full Text] [Related]
10. Aggrecanases and cartilage matrix degradation.
Nagase H; Kashiwagi M
Arthritis Res Ther; 2003; 5(2):94-103. PubMed ID: 12718749
[TBL] [Abstract][Full Text] [Related]
11. [Aggrecanases and osteoarthritis].
Li C; Cao YP; Guan ZP; Huang de Y; Ge ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):611-2. PubMed ID: 19829688
[TBL] [Abstract][Full Text] [Related]
12. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.
Moncada-Pazos A; Obaya AJ; Viloria CG; López-Otín C; Cal S
J Mol Med (Berl); 2011 Jun; 89(6):611-9. PubMed ID: 21365186
[TBL] [Abstract][Full Text] [Related]
13. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes.
Tortorella MD; Arner EC; Hills R; Easton A; Korte-Sarfaty J; Fok K; Wittwer AJ; Liu RQ; Malfait AM
J Biol Chem; 2004 Apr; 279(17):17554-61. PubMed ID: 14715656
[TBL] [Abstract][Full Text] [Related]
14. Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition.
Cuffaro D; Ciccone L; Rossello A; Nuti E; Santamaria S
J Med Chem; 2022 Oct; 65(20):13505-13532. PubMed ID: 36250680
[TBL] [Abstract][Full Text] [Related]
15. The cleavage of biglycan by aggrecanases.
Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
[TBL] [Abstract][Full Text] [Related]
16. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system.
Powell AJ; Little CB; Hughes CE
Arthritis Rheum; 2007 Sep; 56(9):3010-9. PubMed ID: 17763444
[TBL] [Abstract][Full Text] [Related]
18. Aggrecanases in the human synovial fluid at different stages of osteoarthritis.
Zhang E; Yan X; Zhang M; Chang X; Bai Z; He Y; Yuan Z
Clin Rheumatol; 2013 Jun; 32(6):797-803. PubMed ID: 23370724
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.
Stanton H; Rogerson FM; East CJ; Golub SB; Lawlor KE; Meeker CT; Little CB; Last K; Farmer PJ; Campbell IK; Fourie AM; Fosang AJ
Nature; 2005 Mar; 434(7033):648-52. PubMed ID: 15800625
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
Troeberg L; Fushimi K; Scilabra SD; Nakamura H; Dive V; Thøgersen IB; Enghild JJ; Nagase H
Matrix Biol; 2009 Oct; 28(8):463-9. PubMed ID: 19643179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
